This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: John Meyer: Innovator in Growth Hormone Preparation
Introduction
John Meyer is a notable inventor based in Ellisville, MO (US). He has made significant contributions to the field of biotechnology, particularly in the preparation of growth hormones. His innovative methods have the potential to enhance the quality and efficacy of hormone treatments.
Latest Patents
Meyer holds a patent for a "Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof." This invention focuses on recombinant methods for producing polypeptides with reduced isoform impurities. Specifically, it addresses the preparation of growth hormone and its antagonist, pegvisomant, while minimizing impurities such as trisulfide and des-phe isoform impurities.
Career Highlights
John Meyer is associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to advancements in hormone therapies, which are crucial for various medical applications. His patent reflects his commitment to improving the safety and effectiveness of these treatments.
Collaborations
Meyer has collaborated with notable colleagues, including Stephen B Lyle and Scott I Allen. These partnerships have likely fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
John Meyer is a distinguished inventor whose work in the preparation of growth hormones has the potential to impact medical treatments significantly. His innovative methods and collaborations highlight his dedication to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
